Log in
Enquire now
‌

US Patent 7104972 Injection device with a dose setting limiter

Patent 7104972 was granted and assigned to Novo Nordisk on September, 2006 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Novo Nordisk
Novo Nordisk
Date Filed
July 1, 2003
Date of Patent
September 12, 2006
Patent Application Number
10610926
Patent Citations Received
‌
US Patent 12076160 Alarms and alerts for medication delivery devices and systems
0
‌
US Patent 11696986 Multiple use disposable injection pen
0
‌
US Patent D994111 Medicament delivery device cover
0
‌
US Patent D994110 Medicament delivery device cover
0
‌
US Patent 12064591 Infusion pump system and method
0
‌
US Patent 11752198 GLP-1 compositions and uses thereof
‌
US Patent 11771830 Medicament delivery device and methods for delivering drugs to infants and children
‌
US Patent 11865299 Infusion pump systems and methods
0
‌
US Patent D1011520 Medicament delivery device and cover assembly
0
‌
US Patent 11957888 Personalizing preset meal sizes in insulin delivery system
0
•••
Patent Inventor Names
Steffen Hansen
0
Christian Sorensen
0
Claus Schmidt Moller
0
Thomas Dedenroth Miller
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7104972
Patent Primary Examiner
Nicholas D Lucchesi
Nicholas D Lucchesi

Find more entities like US Patent 7104972 Injection device with a dose setting limiter

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.